Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1996 2
1997 2
1998 3
1999 1
2000 5
2001 2
2002 1
2003 1
2004 1
2005 2
2006 1
2007 2
2008 2
2009 4
2010 7
2011 6
2012 6
2013 5
2014 10
2015 12
2016 15
2017 13
2018 19
2019 17
2020 12
2021 12
2022 16
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia.
Fan R, Satilmis H, Vandewalle N, Verheye E, De Bruyne E, Menu E, De Beule N, De Becker A, Ates G, Massie A, Kerre T, Törngren M, Eriksson H, Vanderkerken K, Breckpot K, Maes K, De Veirman K. Fan R, et al. Among authors: maes k. Blood Cancer J. 2023 Dec 18;13(1):188. doi: 10.1038/s41408-023-00962-z. Blood Cancer J. 2023. PMID: 38110349 Free PMC article.
Metabolic Features of Multiple Myeloma.
El Arfani C, De Veirman K, Maes K, De Bruyne E, Menu E. El Arfani C, et al. Among authors: maes k. Int J Mol Sci. 2018 Apr 14;19(4):1200. doi: 10.3390/ijms19041200. Int J Mol Sci. 2018. PMID: 29662010 Free PMC article. Review.
Off-clamp Versus On-clamp Robot-assisted Partial Nephrectomy: A Propensity-matched Analysis.
Sharma G, Shah M, Ahluwalia P, Dasgupta P, Challacombe BJ, Bhandari M, Ahlawat R, Rawal S, Buffi NM, Sivaraman A, Porter JR, Rogers C, Mottrie A, Abaza R, Rha KH, Moon D, Yuvaraja TB, Parekh DJ, Capitanio U, Maes KK, Porpiglia F, Turkeri L, Gautam G. Sharma G, et al. Among authors: maes kk. Eur Urol Oncol. 2023 Oct;6(5):525-530. doi: 10.1016/j.euo.2023.04.005. Epub 2023 May 14. Eur Urol Oncol. 2023. PMID: 37193626
Peripheral precocious puberty in Li-Fraumeni syndrome: a case report and literature review of pure androgen-secreting adrenocortical tumors.
Ryckx S, De Schepper J, Giron P, Maes K, Vaeyens F, Wilgenhof K, Lefesvre P, Ernst C, Vanderlinden K, Klink D, Hes F, Vanbesien J, Gies I, Staels W. Ryckx S, et al. Among authors: maes k. J Med Case Rep. 2023 May 14;17(1):195. doi: 10.1186/s13256-023-03889-y. J Med Case Rep. 2023. PMID: 37179382 Free PMC article. Review.
The therapeutic potential of cell cycle targeting in multiple myeloma.
Maes A, Menu E, Veirman K, Maes K, Vand Erkerken K, De Bruyne E. Maes A, et al. Among authors: maes k. Oncotarget. 2017 Jun 28;8(52):90501-90520. doi: 10.18632/oncotarget.18765. eCollection 2017 Oct 27. Oncotarget. 2017. PMID: 29163849 Free PMC article. Review.
RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma.
Emde-Rajaratnam M, Beck S, Benes V, Salwender H, Bertsch U, Scheid C, Hänel M, Weisel K, Hielscher T, Raab MS, Goldschmidt H, Jauch A, Maes K, De Bruyne E, Menu E, De Veirman K, Moreaux J, Vanderkerken K, Seckinger A, Hose D. Emde-Rajaratnam M, et al. Among authors: maes k. Front Immunol. 2023 Nov 15;14:1286700. doi: 10.3389/fimmu.2023.1286700. eCollection 2023. Front Immunol. 2023. PMID: 38035078 Free PMC article.
183 results